BDBM649457 US11890279, Compound A13

SMILES CC(C)Oc1cccc(c1)C(=O)Nc1cccc2ccc(C)nc12

InChI Key InChIKey=HRNIDDMXOHDEJD-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 649457   

TargetAdenosine receptor A2a(Human)
Neurodon

US Patent
LigandPNGBDBM649457(US11890279, Compound A13)
Affinity DataEC50: <2.00E+4nMAssay Description:The administration of the test compound as a SERCA agonist led to improvement in ER function as evidenced by the expression protein markers of ER str...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649457(US11890279, Compound A13)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for cardiac SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Neurodon

US Patent
LigandPNGBDBM649457(US11890279, Compound A13)
Affinity DataEC50: <2.00E+4nMAssay Description:Assay is for skeletal SR.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2024
Entry Details
Go to US Patent